• Journal of Digestive Cancer Research
• /
• 제10권1호
• /
• pp.31-38
• /
• 2022

Ulcerative colitis (UC) exhibits chronic intestinal inflammatory conditions with cycles of relapse and remission. The incidence is rapidly growing in Asian countries including South Korea possibly due to changes in lifestyles. Although the etiology of inflammatory bowel disease is inconclusive, gut microbiota composition is considered a critical factor involved in the pathogenesis of UC. The overgrowth of pathogenic bacteria evokes hyper-immune responses in gut epithelium causing tissue inflammation and damage. Also, failure to regulate gut epithelium integrity due to chronic inflammation and mucus depletion accelerates bacterial translocation aggravating immune dysregulation. Gut microbiota composition responds to the diet in a very rapid manner. Epidemiological studies have indicated that the risk of UC is associated with low plant foods/high animal foods consumption. Several bacterial strains consistently found depleted in UC patients use plant food-originated dietary fiber producing short chain fatty acids to maintain epithelial integrity. These bacteria also use mucus layer mucin to keep gut microbiota diversity. These studies partly explain the association between dietary modification of gut microbiota in UC development. Further human intervention trials are required to allow the use of specific bacterial strains in the management of UC.

• Mass Spectrometry Letters
• /
• 제15권1호
• /
• pp.49-53
• /
• 2024

Ceramide is a lipid in which sphingoid bases and fatty acids are linked by amide bonds. As a marker of skin disease in the human stratum corneum, its disease-causing and therapeutic effects have been partially confirmed, and it is therefore an important element in commercially available cosmetic formulations. However, structural diversity caused by differences in the chain length, number, and location of hydroxyl groups makes quality control difficult. In this study, a method was established to separate different ceramide species using reversed-phase LC-MS/MS and thus enable qualitative evaluation. Separation of four standards was achieved within a short retention time, and the accuracy and sensitivity of the method were demonstrated by the low limit of detection (LOD) calculated based on the calibration curve showing linearity, with R² > 0.994. After verification of reproducibility and reliability through intra- and inter-day analyses, the efficiency of the method was confirmed through analysis of commercial cosmetic raw materials.

• 한국축산식품학회지
• /
• 제44권1호
• /
• pp.119-131
• /
• 2024

BIOVITA 3 bacterial species (BIOVITA 3), a probiotic blend powder containing Clostridium butyricum IDCC 1301, Weizmannia coagulans IDCC 1201, and Bacillus subtilis IDCC 1101, has been used as a food ingredient for gut health. However, its efficacy in improving constipation has not been reported. Therefore, we aimed to investigate the functional effects of oral administration of BIOVITA 3 as well as its component strains alone (at 1.0×10⁹ CFU/day) in Sprague-Dawley (SD) rats with loperamide-induced constipation. The study included fecal analysis, gastrointestinal transit ratio, histopathological analysis, short chain fatty acids (SCFAs), and metagenome analysis. As results, the BIOVITA 3 group showed significant improvements in fecal number, water content, gastrointestinal transit ratio, and thickening of the mucosal layer. In the SCFAs analysis, all probiotic-treated groups showed an increase in total SCFAs compared to the loperamide-constipated group. Changes in microbial abundance and the diversity index of three groups (normal, constipated, and BIOVITA 3) were also defined. Of these, the BIOVITA 3 showed a significant improvement in loperamide-constipated SD-rats. This study suggests the possibility that BIOVITA 3 can be applied as an ingredient in functional foods to relieve constipation.

• Journal of Microbiology and Biotechnology
• /
• 제34권3호
• /
• pp.487-494
• /
• 2024

Recently, the term metabiotics has emerged as a new concept of probiotics. This concept entails combining existing probiotic components with metabolic by-products improve specific physiological functionalities. Representative ingredients of these metabiotics include short-chain fatty acids (SCFAs), bacteriocins, polysaccharides, and peptides. The new concept is highly regarded as it complements the side effects of existing probiotics and is safe and easy to administer. Known health functions of metabiotics are mainly immune regulation, anti-inflammatory, anticancer, and brain-neurological health. Research has been actively conducted on the health benefits related to the composition of intestinal microorganisms. Among them, the focus has been on brain neurological health, which requires extensive research. This study showed that neurological disorders, such as depression, anxiety, autism spectrum disorder, Alzheimer's disease, and Parkinson's disease, can be treated and prevented according to the gut-brain axis theory by changing the intestinal microflora. In addition, various studies are being conducted on the immunomodulatory and anticancer effects of substances related to metabiotics of the microbiome. In particular, its efficacy is expected to be confirmed through human studies on various cancers. Therefore, developing various health functional effects of the next-generation probiotics such as metabiotics to prevent or treatment of various diseases is anticipated.

• Journal of Microbiology and Biotechnology
• /
• 제34권4호
• /
• pp.747-756
• /
• 2024

Chronic gut inflammation promotes the development of metabolic diseases such as obesity. There is growing evidence which suggests that dysbiosis in gut microbiota and metabolites disrupt the integrity of the intestinal barrier and significantly impact the level of inflammation in various tissues, including the liver and adipose tissues. Moreover, dietary sources are connected to the development of leaky gut syndrome through their interaction with the gut microbiota. This review examines the effects of these factors on intestinal microorganisms and the communication pathways between the gut-liver and gut-brain axis. The consumption of diets rich in fats and carbohydrates has been found to weaken the adherence of tight junction proteins in the gastrointestinal tract. Consequently, this allows endotoxins, such as lipopolysaccharides produced by detrimental bacteria, to permeate through portal veins, leading to metabolic endotoxemia and alterations in the gut microbiome composition with reduced production of metabolites, such as short-chain fatty acids. However, the precise correlation between gut microbiota and alternative sweeteners remains uncertain, necessitating further investigation. This study highlights the significance of exploring the impact of diet on gut microbiota and the underlying mechanisms in the gut-liver and gut-brain axis. Nevertheless, limited research on the gut-liver axis poses challenges in comprehending the intricate connections between diet and the gut-brain axis. This underscores the need for comprehensive studies to elucidate the intricate gut-brain mechanisms underlying intestinal health and microbiota.

• 대한유전성대사질환학회지
• /
• 제15권1호
• /
• pp.40-43
• /
• 2015

Short-chain acyl-CoA dehydrogenase (SCAD) deficiency is an autosomal recessive mitochondrial disorder of fatty acid oxidation associated with mutations in the ACADS gene. While patients diagnosed clinically have a variable clinical presentation, patients diagnosed by newborn screening are largely asymptomatic. We describe here the case of a 1-year-old male patient who was detected by newborn screening and diagnosed as SCAD deficiency. Spectrometric screening for inborn errors of metabolism at 72hrs after birth showed elevated butyrylcarnitine (C4) level of 1.69 mol/L (normal, <0.83 mol/L), C4/C2 ration of 0.26 (normal, <0.09), C5DC+C60H level of 39 mol/L (normal, <0.28 mol/L), and C5DC/C8 ration of 7.36 (normal, <4.45). The follow-up testing at 18 days of age were performed: liquid chromatography tandem mass spectrometry (LC-MS/MS), urine organic acids, and quantitative acylcarnitine profile. C4 carnitine was elevated as 0.91; urine organic acid analysis showed elevated ethylmalonic acid as 62.87 nmol/molCr (normal, <6.5), methylsuccinate 6.81 nmol/molCr (normal, not detected). Sequence analysis of ACADS revealed a homozygous missense mutation, c.164C>T (p.Pro55Leu). He is growing well and no episodes of seizures or growth retardation had occurred.

• 한국수산과학회지
• /
• 제34권2호
• /
• pp.84-90
• /
• 2001

저분자 alginate인 HAG-10, HAG-50, HAG-100 및 alginate를 랫드에 장기간 섭취시켰을 때, 분변의 무게와 수분함량, 단백질과 지방함량, pH, VBN 및 단쇄지방산을 측정하여 소화생리특성에 미치는 영향에 대하여 검토하였으며, 그 결과를 요약하면 다음과 같다. 랫드분변의 무게와 수분함량의 변화는 alginate에서 가장 높은 증가를 보였고, 다음으로 HAG-100, HAG-50이었으며 HAG-10은 투여전과 거의 변화가 없었다. 분변의 단백질과 지방함량은 $5\%$ HAG-50에서 가장 높았고, 그 소화율은 $5\%$와 $10\%$ HAG-50에서 유의적으로 현저히 저하하였다. 분변의 pH는 $5\%$와 $10\%$ HAG-50에서 급격하게 저하하였으나, $10\%$ HAG-100과 alginate에서는 오히려 급격히 증가하는 경향을 나타내었다. VBN은 $10\%$ HAG-10, HAG-50 모두 그리고 $1\%$와 $5\%$ HAG-100에서 뚜렷한 저하를 보였으나, $10\%$ HAG-100 및 $5\%$와 $10\%$ alginate는 반대로 급격히 증가하였다. 단쇄지방산의 변화는 $5\%$와 $10\%$ HAG-50에서 n-butyric acid가 증가하였고, propionic acid와 acetic acid는 반대로 현저히 감소하였다. 이상의 결과로부터, HAG-50은 랫드 분변의 pH와 VBN을 현저히 저하시켰으며, 단쇄지방산중 n-butyric acid를 증가시키고 propionic acid와 acetic acid를 유의적으로 감소시켰으므로, 랫드의 소화생리특성을 개선시키는 데 있어서 효과적인 저분자 alginate라고 사료된다.

• 생명과학회지
• /
• 제22권11호
• /
• pp.1571-1586
• /
• 2012

지구상에는 약 5,400여 종의 포유동물이 있고 그 중 약 1,000여 종은 풀을 뜯어 먹고 사는 초식동물이다. 초식동물 중에서 약 250여 종이 반추동물로 알려져 있다. 반추동물인 소와 양은 반추위에서 주로 발효가 일어나지만 비반추동물인 돼지와 사람은 맹장과 결장, 직장에서 주로 발효가 일어난다. 반추위 미생물의 종류와 우점도 Bacteroidetes 51%, Firmicutes 43% 존재하며, 사람의 대장미생물의 우점도Firmicutes 65%, Bacteroidetes 25%로 존재한다. 풀의 세포벽 구성성분은 미생물에 의해 분해, 발효에 의해 SCFA (short chain fatty acid)를 생성하게 되고 acetate, propionate, butyrate 생성비율은 60:25:15이다. 장내 primary butyrate transporter인 MCT1(monocarboxylatetransports-1)에 의해서 흡수된 butyrate는 SCFA receptor GPR43과 GPR41을 활성화시킨다. Butyrate는 강력한 anti-tumorigenic 기능을 가지고 있다. Butyrate는 다양한 cancer cell에 효과를 나타내며 세포내의 기능 조절에 기여하고, 암세포사멸을 유도하는 특성이 있다. Butyrate는 caspase의 활성화, HDAC (histone deacetylase) 활성을 억제하여apoptosis를 유도하고, p53 발현증가로 cell cycle arrest와 apoptosis를 유도한다. SCFA의 항 염증작용으로는 장 상피세포에서 IL-8 발현 감소, NO합성과 NF-${\kappa}B$ (nuclear factor ${\kappa}B$)의 활성을 억제하여 염증으로 인한 암 발생을 억제한다. Butyrate는 장 점막의 생리적 기능을 유지하는데 중요한 역할을 하며 IBD (inflammatory bowel disease) 치료법으로 이용되고 있다.

• 한국식품영양과학회지
• /
• 제34권3호
• /
• pp.351-355
• /
• 2005

식이섬유의 기능을 가지는 저항전분(HM: HI-MAIZE)과 저항전분에 차전자피를 포함한 탄수화물로 구성된 D-factor를 10% 가하여 제조한 식이섬유(HM-D: HI-MAIZE DIET)의 특성을 비교하기 위하여 glucose 및 bile acid 흡수저해효과 및 장내 세균에 의한 혐기적 발효산물인 단쇄지방산의 함량을 각각 비교하였다 반투막을 이용하여 glucose흡수저해효과를 측정한 결과, HM에 비하여 HM-D의 경우 glucose 저해효과가 다소 우세한 것으로 나타났으며, 투석 막을 통한 glucose 투과는 4시간 경과 시 HM은 77%와 HM-D는 68%를 보였으며, 24시간까지 연장시 glucose는 거의 전부 투과되었다. 투석 막을 이용한 bile acid 흡수저해효과는 HM시료에 비하여 D-factor가 첨가된 저항전분의 경우 bile acid 흡수저해효과가 우수함을 알 수 있었으며, 투석막을 통한 bile acid 투과는 서서히 일어났으며 24시간 경과 시 HM과 HM-D의 경우 65%와 62.3%의 bile acid 투과가 이루어 졌다. 장내 세균에 의한 단쇄지방산 생성은 HM의 경우 217.8mM, HM-D는 264.0mM로 HM-D의 경우 더 많은 양의 단쇄지방산의 생성량을 보였으며, butyric acid 생성 양은 HM-D가 32.7mM로 26.9mM생성량을 보인 HM에 비하여 높았다. 따라서 D-factor첨가에 의해 glucose와 bile acid의 흡수저해 효과가 증가하였을 뿐만 아니라 단쇄지방산의 함량과 butyric acid함량 증가를 보임에 따라 D-factor첨가에 의해 저항전분이 지니는 식이섬유의 기능이 강화되었다.

• Journal of Microbiology and Biotechnology
• /
• 제32권7호
• /
• pp.927-937
• /
• 2022

To confirm the therapeutic effect of the water extract from Ecklonia cava (WEE) against PM_2.5 induced systemic health damage, we evaluated gut health with a focus on the microbiota and metabolites. Systemic damage in mice was induced through PM_2.5 exposure for 12 weeks in a whole-body chamber. After exposure for 12 weeks, body weight and food intake decreased, and WEE at 200 mg/kg body weight (mpk) alleviated these metabolic efficiency changes. In addition, PM_2.5 induced changes in the length of the colon and fecal water content. The administration of the WEE at 200 mpk oral dose effectively reduced changes in the colon caused by PM_2.5 exposure. We also attempted to confirm whether the effect of the WEE is mediated via regulation of the microbiota-gut-brain axis in mice with PM_2.5 induced systemic damage. We examined changes in the fecal microbiota and gut metabolites such as short-chain fatty acids (SCFAs) and kynurenine metabolites. In the PM_2.5 exposed group, a decrease in the abundance of Lactobacillus (Family: Lactobacillaceae) and an increase in the abundance of Alistipes (Family: Rikenellaceae) were observed, and the administration of the WEE showed a beneficial effect on the gut microbiota. In addition, the WEE effectively increased the levels of SCFAs (acetate, propionate, and butyrate). Furthermore, kynurenic acid (KYNA), which is a critical neuroprotective metabolite in the gut-brain axis, was increased by the administration of the WEE. Our findings suggest that the WEE could be used as a potential therapeutic against PM_2.5 induced health damage by regulating gut function.